FDA Inspection 1215838 — Actavis Elizabeth LLC

Actavis Elizabeth LLC — FEI 2211563

The FDA completed an inspection of Actavis Elizabeth LLC on July 24, 2023 in Elizabeth, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 24, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Elizabeth, NJ (United States)